Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.
about
Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopesPathways of antigen processing.Diminished intracellular invariant chain expression after vaccinia virus infection.'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptidesMechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrolElevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsDestination 'lysosome': a target organelle for tumour cell killing?HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognitionExpression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes.Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.Quantitating MHC class II trafficking in primary dendritic cells using imaging flow cytometryComplex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cellsA role for Rap2 in recycling the extended conformation of LFA-1 during T cell migration.Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cellsGamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis.Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.Hypoxia increases membranal and secreted HLA-DR in endothelial cells, rendering them T-cell activators.LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.HLA class II antigen presentation by prostate cancer cells.Role of keratinocytes in antigen presentation and polarization of human T lymphocytes.Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.Igβ ubiquitination activates PI3K signals required for endosomal sorting.DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis.Myosin 1g Contributes to CD44 Adhesion Protein and Lipid Rafts Recycling and Controls CD44 Capping and Cell Migration in B Lymphocytes.Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage.
P2860
Q24674180-559F9723-567C-444B-A100-248BE1195813Q33631854-E47C9EB6-00D3-4BA4-90D2-E3FE52963C07Q33747640-B07EC1CA-8198-47A0-8875-E201DE45E7F2Q34091080-ED83C675-5685-4BDD-9E70-43C4862721E4Q34870725-AC8E5F93-2D05-495F-AB83-1C1BBBFAD0FAQ35071179-41664DFC-08B2-473E-B20A-F95F53F36AE8Q35549436-B355D3B1-31A2-4C43-9EFA-4E7F846B22D4Q35582198-7EB79FE2-7785-4757-A1CA-9827E3AF8C22Q35646849-F7295187-851F-4421-9F9D-BD101546185BQ35749609-0FEEFE59-19B2-4DE5-A6AA-60C794C35DAAQ35908490-B25D4B30-509E-409C-87DB-E33440C608EBQ36371928-05FFD5D7-1B90-463F-98AE-E79DCBF9D6BCQ36425532-DCE34B39-1293-44CF-8446-7A24D39933DEQ36478578-BAF87115-3DFB-44CD-BA96-432B3AD98D02Q37469304-5E0CF02B-41CC-414C-A9F5-8B6A53BD6AFEQ38167996-6F9D507F-C200-4A0C-B3EA-86045968EB13Q38844774-5AA6D8DB-7D00-4C22-8C94-CBD39F841E52Q38978579-569C0A79-E459-4CCB-9DF2-C8E5E1EB84FFQ39015659-07B00BF2-4653-4EFA-908E-CB2CAB338D40Q39497103-ED1E8759-D510-4B5E-A38C-5B782E5D490BQ39697429-D1F18234-3B3B-4C8A-BE21-591CA847F76BQ40067331-8D1909A5-058C-413F-8CD8-3487D125E5A8Q40572452-BAF0FEF0-48F2-4CDB-B320-C1E969CA3FB6Q44623197-91B3292D-B5EE-4967-904B-5EBB94872918Q46075584-C1ACA38C-E77E-41F9-B916-33AFC880B3A9Q46509529-351DFC71-7D3B-4502-8C9F-C3D4BDB670DCQ49177430-0C7CC458-14ED-4489-AB16-02E2B894E503Q50673173-AEEE3A80-7175-4F86-8E2E-D14623CFA968Q53272970-8580A0C8-A28A-421F-86B1-447782E2E44D
P2860
Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Endocytic recycling is require ...... de via MHC class II molecules.
@en
type
label
Endocytic recycling is require ...... de via MHC class II molecules.
@en
prefLabel
Endocytic recycling is require ...... de via MHC class II molecules.
@en
P2860
P1433
P1476
Endocytic recycling is require ...... de via MHC class II molecules.
@en
P2093
P2860
P304
P356
10.1034/J.1600-0854.2000.010706.X
P577
2000-07-01T00:00:00Z